BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1259412)

  • 21. Enhancement of interferon production by poly(rI)-poly(rC) in mouse cell cultures by ascorbic acid.
    Siegel BV
    Nature; 1975 Apr; 254(5500):531-2. PubMed ID: 1121329
    [No Abstract]   [Full Text] [Related]  

  • 22. Elimination of polynucleotide-induced hyporeactivity in mice treated with interferon and antitumor therapy.
    Imanishi J; Kita M; Sugino S; Oku T; Kishida T
    J Interferon Res; 1982; 2(1):65-74. PubMed ID: 6180107
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interferon production by human-mouse hybrid cells: dominant mouse control of superinduction and priming.
    Graves HE; Meager A
    J Gen Virol; 1980 Apr; 47(2):489-95. PubMed ID: 6154131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of interferon inducers on colony stimulating factor production in L cell cultures.
    Havredaki M; McNeill TA
    J Gen Virol; 1975 Apr; 27(1):107-10. PubMed ID: 1170275
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polyriboinosinic-polyribocytidylic acid-poly-L-lysine complex [poly(ICL)] without carboxymethylcellulose (CMC): a new primate-effective interferon inducer.
    Riley FL; Morin ML; Lvovsky E; Stephens EE; Levy HB
    Proc Soc Exp Biol Med; 1982 Feb; 169(2):183-8. PubMed ID: 6174989
    [No Abstract]   [Full Text] [Related]  

  • 26. Rapid onset of hyporesponsiveness to interferon induction on re-exposure to polyribonucleotide.
    Breinig MC; Armstrong JA; Ho M
    J Gen Virol; 1975 Feb; 26(2):149-58. PubMed ID: 1167574
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Requirement for macrophages for interferon to be effective against encephalomyocarditis virus infection of mice.
    Stebbing N; Dawson KM; Lindley IJ
    Infect Immun; 1978 Jan; 19(1):5-11. PubMed ID: 203537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Herpesvirus saimiri: in vitro sensitivity to virus-induced interferon and to polyriboinosinic acid: polyribocytidylic acid.
    Barahona HH; Melendez LV
    Proc Soc Exp Biol Med; 1971 Apr; 136(4):1163-7. PubMed ID: 4324740
    [No Abstract]   [Full Text] [Related]  

  • 29. Kinetic and metabolic studies on the priming effect of interferon in L cells.
    Rosztóczy I
    Arch Immunol Ther Exp (Warsz); 1977; 25(5):631-9. PubMed ID: 597012
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Study of the priming effect of interferon in L cells. I. The primed interferon response and the kinetics of development of priming.
    Rosztóczy I
    Acta Virol; 1976 Dec; 20(6):472-8. PubMed ID: 13642
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Priming: a nonantiviral function of interferon.
    Stewart WE; Gosser LB; Lockart RZ
    J Virol; 1971 Jun; 7(6):792-801. PubMed ID: 4327587
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interferon induction and its dependence on the primary and secondary structure of poly(inosinic acid).poly(cytidylic acid).
    Greene JJ; Alderfer JL; Tazawa I; Tazawa S; Ts'o PO; O'Malley JA; Carter WA
    Biochemistry; 1978 Oct; 17(20):4214-20. PubMed ID: 708705
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cellular alteration by interferon: a virus-free system for assaying interferon.
    Stewart WE; De Clercq E; De Somer P
    J Virol; 1972 Nov; 10(5):896-901. PubMed ID: 4344256
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of ionenes on interferon induction by poly(inosinic acid) . poly(cytidylic acid).
    Clercq ED; Janik B; Sommer RG
    Antimicrob Agents Chemother; 1977 Apr; 11(4):756-9. PubMed ID: 856030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Susceptibility of various cells treated with interferon to the toxic effect of poly(rI).poly(rC) treatment.
    Emeny JM; Morgan MJ
    J Gen Virol; 1979 Apr; 43(1):253-5. PubMed ID: 113495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endogenous pyrogen formation by human blood monocytes stimulated by polyriboinosinic acid:polyribocytidylic acid.
    Won SJ; Lin MT
    Experientia; 1993 Feb; 49(2):157-9. PubMed ID: 7680005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Physical and biological properties of deae-dextran--polyriboinosinic: polyribocytidylic acid complexes.
    Mécs I; Rosztóczy I
    Acta Virol; 1971 Jul; 15(4):280-5. PubMed ID: 4398078
    [No Abstract]   [Full Text] [Related]  

  • 38. Interaction of polyriboinosinic acid, polyribocytidylic acid with human lymphoblastoid cells.
    Volckaert-Vervliet G; De Clercq E; Billiau A
    Biochem Biophys Res Commun; 1980 Feb; 92(3):833-8. PubMed ID: 6244818
    [No Abstract]   [Full Text] [Related]  

  • 39. Isolation and biological characterization of mouse LM fibroblast variants resistant to the cytotoxicity of polyriboinosinic polyribocytidylic acid after interferon treatment.
    Faure T; Milhaud PG; Fruteau de Laclos H; Mechti N; Silhol M; Huez G; Lebleu B
    J Gen Virol; 1984 Mar; 65 ( Pt 3)():617-27. PubMed ID: 6199456
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A systematic study of interferon production by mouse L-929 cells induced with poly(I).poly(C) and DEAE-dextran.
    Trapman J
    FEBS Lett; 1979 Feb; 98(1):107-10. PubMed ID: 428525
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.